C13.1 ICD 10 Code is a billable and specific code that can be used to indicate a diagnosis of Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect for reimbursement purposes. The 2023 edition of the American ICD-10-CM code became effective on October 1, 2022.

Short description for C13.1 ICD 10 code:

Malig neoplasm of aryepiglottic fold, hypopharyngeal aspect

Type 2 excludes for C13.1 ICD 10 code
  • malignant neoplasm of aryepiglottic fold or interarytenoid fold, laryngeal aspect (C32.1)

Possible back-references that may be applicable or related to C13.1 ICD10 Code:

Present On Admission (POA Exempt)

C13.1 ICD 10 code is considered exempt from POA reporting

Clinical information about C13.1 ICD 10 code

Throat cancer is a type of head and neck cancer. Throat cancer has different names, depending on which part of the throat is affected. The different parts of your throat are called the oropharynx, the hypopharynx, the nasopharynx, and the larynx, or voice box.

The main risk factors for throat cancer are using tobacco heavy drinking. Certain types of throat cancer also have other risk factors. For example, having HPV is a risk factor for oropharyngeal cancer.

Symptoms of throat cancer may include:

  • A sore throat that does not go away
  • A lump in the neck
  • Pain or ringing in the ears
  • Trouble swallowing
  • Ear pain

To diagnose throat cancers, doctors may do a physical exam and history, imaging tests, and a biopsy. You may also need other tests, depending on the type of cancer. Treatments include surgery, radiation therapy, and chemotherapy. Treatment for some types of throat cancer may also include targeted therapy. Targeted therapy uses drugs or other substances that attack specific cancer cells with less harm to normal cells.

NIH: National Cancer Institute

The information in this box was provided by MedlinePlus.gov